Valneva’s Inactivated Covid-19 Vaccine Aces Phase III Trial
Last week, the French vaccine maker Valneva announced promising phase III trial results of its…
Last week, the French vaccine maker Valneva announced promising phase III trial results of its…
In a significant step in the fight against tropical disease, the mosquito-borne viral disease chikungunya…
Last month saw huge biotech investment rounds dedicated to Covid-19 vaccines in Europe, including IPOs…
The French biotech Valneva will collaborate with Pfizer to develop and commercialize Valneva’s phase II-stage…
Update (18/11/2019): French biotech Valneva has revealed additional phase I results concerning its experimental chikungunya…
Sometimes things don’t go your way in the biotech industry. The CEO of Valneva, Thomas…
Results from a Phase I trial showed promising safety and efficacy of a potential first…
There is currently no vaccine for the fast-growing disease in the US, & treatments cost…
French Valneva continues to sign license agreements for its duck derived stem cell line that produces…
A few months ago, the article "An Anglo-French Partnership To Cure Hepatitis B" related Valneva…
European biotechnology company Valneva and UK company Immune Targeting Systems (ITS) announced that they have…